Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK0431 (Sitagliptin) Early Phase II Study in Type 2 Diabetes
NCT00371007Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2004
- Primary completion
- Apr 2005
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by Merck & Co.. Started Jun 2004; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00371007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00371007.